Molecular Docking Study Of Potential Drug Candidates Against Borreliosis
MetadataShow full item record
Lyme borreliosis is one of the most common tick-borne infections, for which there is an extensive need to find a new drug. For this purpose our in silico docking study was carried out to identify drug-likeness of chosen small molecules – potential borreliosis drugs. Its results revealed that BesA compound (C2 form) – a membrane fusion protein present in Borrelia burgdorferi, can play a significant role as a possible drug target compound and therefore it should be further examined in development of potential drugs for Lyme borreliosis treatment.
Document typePeer reviewed
Document versionxmlui.vut.verze.Publishers's version
SourceProceedings of the 23st Conference STUDENT EEICT 2017. s. 339-343. ISBN 978-80-214-5496-5
- Student EEICT 2017